Yoshihiro Shibata

Fukuoka, 8110213, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)".

Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)".

Journal: Journal of medicinal chemistry

Published: May 08, 2025

Usefulness of Pathological Autopsy for Patients With Malignant Tumors.

Usefulness of Pathological Autopsy for Patients With Malignant Tumors.

Journal: Cureus

Published: January 28, 2025

Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).

Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).

Journal: Journal of medicinal chemistry

Published: March 11, 2024

Myocardial metastasis from ZEB1- and TWIST-positive spindle cell carcinoma of the esophagus: A case report.

Myocardial metastasis from ZEB1- and TWIST-positive spindle cell carcinoma of the esophagus: A case report.

Journal: World journal of gastroenterology

Published: January 19, 2024

Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

Journal: Nature communications

Published: December 13, 2023

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.

Journal: Cancer immunology, immunotherapy : CII

Published: February 01, 2023

Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use.

Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use.

Journal: ACS medicinal chemistry letters

Published: January 12, 2023

Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma.

Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma.

Journal: Molecular cancer therapeutics

Published: May 02, 2022

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.

Journal: British journal of cancer

Published: October 28, 2019

Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies.

Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies.

Journal: Brachytherapy

Published: September 29, 2019

Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.

Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.

Journal: ACS medicinal chemistry letters

Published: December 14, 2018

Efforts toward Patient Safety: Development of System and Education of Non-Technical Skill

Efforts toward Patient Safety: Development of System and Education of Non-Technical Skill

Journal: Igaku butsuri : Nihon Igaku Butsuri Gakkai kikanshi = Japanese journal of medical physics : an official journal of Japan Society of Medical Physics

Published: November 02, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026